From Code to Care: Combating Business Crime in Today's Innovative and Traditional Healthcare Sector
Florence, Italy
23 April 2026 - 25 April 2026
From Code to Care: Combating Business Crime in Today's Innovative and Traditional Healthcare Sector
Thursday 23 April 2026 | |
| 17:30 | Registrations open in Grand Hotel Baglioni |
| 18:00 » 21:00 | Welcome Reception and cocktail dinner in Grand Hotel Baglioni |
Friday 24 April 2026 | |
| 09:00 » 09:30 | Welcome address by AIJA President |
| 09:30 » 10:00 | Keynote speech |
| 10:00 » 11:00 | Session 1: Combating corruption in healthcare practices This panel will explore the challenge of corruption within healthcare systems, including issues like bribery, bid rigging, fraudulent contract awarding, and conflicts of interest. Experts will discuss strategies for mitigating these risks, focusing on transparent practices (including in public procurement), regulatory oversight, and the use of technology in promoting accountability. The discussion will also cover the broader impact of corruption on healthcare delivery, patient care, and overall costs, emphasizing the importance of ethical conduct among healthcare professionals at all levels, as well as real-life examples of how criminal litigation has been tackled in similar matters. |
| 11:00 » 11:30 | Coffee Break |
| 11:30 » 12:30 | Session 2: The role of technology in preventing healthcare fraud This discussion will focus on innovative technological solutions like artificial intelligence, blockchain, and machine learning, which are being used to detect fraudulent billing, identity theft, and other fraudulent activities. Panelists will also highlight how data analytics can improve the accuracy of fraud detection in healthcare. |
| 12:30 » 13:30 | Lunch break |
| 13:30 » 14:30 | Session 3: Data breaches and healthcare privacy: fighting crime in a digital world With healthcare systems storing vast amounts of sensitive personal data, the threat of data breaches is a growing concern. This panel will delve into the risks of cyberattacks and the methods criminals use to exploit vulnerabilities in healthcare IT infrastructure. Experts will examine the steps healthcare organizations can take to safeguard patient information and respond to data breaches, as well as the legal and ethical implications of privacy violations (including how to deal with doctor’s privileged information in a criminal investigation). Additionally, the rise of telemedicine has introduced new avenues for fraud, including fake appointments, fraudulent claims, and misrepresentation of services. Panelists will examine the regulatory challenges, best practices for telemedicine providers, and technologies that can help identify and prevent fraud in virtual healthcare settings." |
| 14:30 » 15:00 | Coffee Break |
| 15:00 » 16:00 | Session 4: Healthcare Product liability and fraud As innovation accelerates in healthcare, so do the risks associated with product liability and fraud. This panel will explore the legal, ethical, and operational challenges surrounding defective or misrepresented medical products, from pharmaceuticals to devices. Experts will discuss how fraudulent practices - such as data manipulation, off-label marketing, and failure to disclose risks - can endanger patient safety and erode public trust. Panelists will examine recent high-profile cases, enforcement trends, and the role of whistleblowers, regulators, and internal compliance in detecting and preventing misconduct. The session will highlight proactive strategies for healthcare organizations to manage risk, ensure transparency, and uphold accountability across the product lifecycle. |
| 19:00 » 23:00 | Dinner in Palazzo Borghese |
Saturday 25 April 2026 | |
| 09:30 | Registrations open in Grand Hotel Baglioni |
| 10:00 » 11:00 | Session 5: Antitrust issues in healthcare: combating collusion and price fixing Healthcare markets can sometimes fall victim to anti-competitive behaviors like collusion and price-fixing, leading to inflated costs for patients and insurers (including issues related to vertical agreements imposed by the pharmaceutical companies that create not only antitrust issues but may lead to potentially fraudulent activities of the wholesaler if they do not comply with the contractual restrictions). This panel will explore the role of antitrust law in combating these practices, with a focus on recent cases and regulatory actions aimed at ensuring fair competition in the healthcare sector. Experts will also discuss the implications of consolidation in the healthcare industry and the potential for monopolistic behavior. |
| 11:00 » 11:30 | Coffee Break |
| 11:30 » 12:30 | Session 6: Balancing Ethics and Business in Healthcare: Corporate Responsibility, Integrity, and Patient-Centered Care This panel will examine the intersection of corporate social responsibility (CSR) and ethical dilemmas in the healthcare industry, focusing on how organizations can align business practices with patient care and public trust. Panelists will explore how CSR frameworks - including environmental, social, and governance (ESG) considerations - can help healthcare companies prevent business abuse, while promoting transparency, accountability, and long-term community benefit. The discussion will also address the ethical challenges of balancing profitability with patient well-being, such as misleading marketing, overcharging, unnecessary treatments, and premature drug access. Through real-world case studies and expert insights, attendees will learn how to navigate conflicts of interest, prioritize ethical decision-making, and implement responsible business strategies that protect patients while maintaining financial integrity. |
| 12:30 » 14:00 | Lunch Break |